Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Non-tumor tissue derived interleukin-17B activates IL-17RB/AKT/β-catenin pathway to enhance the stemness of gastric cancer.

Bie Q, Sun C, Gong A, Li C, Su Z, Zheng D, Ji X, Wu Y, Guo Q, Wang S, Xu H.

Sci Rep. 2016 May 5;6:25447. doi: 10.1038/srep25447.

2.

The roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunity.

Song X, He X, Li X, Qian Y.

Cell Mol Immunol. 2016 Jul;13(4):418-31. doi: 10.1038/cmi.2015.105. Epub 2016 Mar 28. Review.

3.

Hyperinsulinemia enhances interleukin-17-induced inflammation to promote prostate cancer development in obese mice through inhibiting glycogen synthase kinase 3-mediated phosphorylation and degradation of interleukin-17 receptor.

Liu S, Zhang Q, Chen C, Ge D, Qu Y, Chen R, Fan YM, Li N, Tang WW, Zhang W, Zhang K, Wang AR, Rowan BG, Hill SM, Sartor O, Abdel-Mageed AB, Myers L, Lin Q, You Z.

Oncotarget. 2016 Mar 22;7(12):13651-66. doi: 10.18632/oncotarget.7296.

4.

Targeting IL-17B-IL-17RB signaling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines.

Wu HH, Hwang-Verslues WW, Lee WH, Huang CK, Wei PC, Chen CL, Shew JY, Lee EY, Jeng YM, Tien YW, Ma C, Lee WH.

J Exp Med. 2015 Mar 9;212(3):333-49. doi: 10.1084/jem.20141702. Epub 2015 Mar 2.

5.

Interleukins and interleukin receptors in rheumatoid arthritis: Research, diagnostics and clinical implications.

Magyari L, Varszegi D, Kovesdi E, Sarlos P, Farago B, Javorhazy A, Sumegi K, Banfai Z, Melegh B.

World J Orthop. 2014 Sep 18;5(4):516-36. doi: 10.5312/wjo.v5.i4.516. eCollection 2014 Sep 18. Review.

6.

Potential role of myeloid cell/eosinophil-derived IL-17 in LPS-induced endotoxin shock.

Shimura E, Shibui A, Narushima S, Nambu A, Yamaguchi S, Akitsu A, Leonard WJ, Iwakura Y, Matsumoto K, Suto H, Okumura K, Sudo K, Nakae S.

Biochem Biophys Res Commun. 2014 Oct 10;453(1):1-6. doi: 10.1016/j.bbrc.2014.09.004. Epub 2014 Sep 6.

7.

Role of Interleukin-17 in defense against pseudomonas aeruginosa infection in lungs.

Xu X, Shao B, Wang R, Zhou S, Tang Z, Lu W, Xiong S.

Int J Clin Exp Med. 2014 Apr 15;7(4):809-16. eCollection 2014.

8.

Potential involvement of IL-17F in asthma.

Ota K, Kawaguchi M, Matsukura S, Kurokawa M, Kokubu F, Fujita J, Morishima Y, Huang SK, Ishii Y, Satoh H, Hizawa N.

J Immunol Res. 2014;2014:602846. doi: 10.1155/2014/602846. Epub 2014 Apr 14. Review.

9.

Interleukin and interleukin receptor gene polymorphisms in inflammatory bowel diseases susceptibility.

Magyari L, Kovesdi E, Sarlos P, Javorhazy A, Sumegi K, Melegh B.

World J Gastroenterol. 2014 Mar 28;20(12):3208-22. doi: 10.3748/wjg.v20.i12.3208. Review.

10.

An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis.

Boisson B, Wang C, Pedergnana V, Wu L, Cypowyj S, Rybojad M, Belkadi A, Picard C, Abel L, Fieschi C, Puel A, Li X, Casanova JL.

Immunity. 2013 Oct 17;39(4):676-86. doi: 10.1016/j.immuni.2013.09.002. Epub 2013 Oct 10.

11.

Codon optimization, expression, purification, and functional characterization of recombinant human IL-25 in Pichia pastoris.

Liu Y, Wu C, Wang J, Mo W, Yu M.

Appl Microbiol Biotechnol. 2013 Dec;97(24):10349-58. doi: 10.1007/s00253-013-5264-4. Epub 2013 Oct 8.

12.

IL-17 family: cytokines, receptors and signaling.

Gu C, Wu L, Li X.

Cytokine. 2013 Nov;64(2):477-85. doi: 10.1016/j.cyto.2013.07.022. Epub 2013 Sep 3. Review.

13.

Parasite-specific IL-17-type cytokine responses and soluble IL-17 receptor levels in Alveolar Echinococcosis patients.

Lechner CJ, Grüner B, Huang X, Hoffmann WH, Kern P, Soboslay PT.

Clin Dev Immunol. 2012;2012:735342. doi: 10.1155/2012/735342. Epub 2012 Aug 30.

14.

The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings.

Martin DA, Towne JE, Kricorian G, Klekotka P, Gudjonsson JE, Krueger JG, Russell CB.

J Invest Dermatol. 2013 Jan;133(1):17-26. doi: 10.1038/jid.2012.194. Epub 2012 Jun 7. Review.

15.

IL-17RA signaling reduces inflammation and mortality during Trypanosoma cruzi infection by recruiting suppressive IL-10-producing neutrophils.

Tosello Boari J, Amezcua Vesely MC, Bermejo DA, Ramello MC, Montes CL, Cejas H, Gruppi A, Acosta Rodríguez EV.

PLoS Pathog. 2012;8(4):e1002658. doi: 10.1371/journal.ppat.1002658. Epub 2012 Apr 26.

16.

IL-17F Induces CCL20 in Bronchial Epithelial Cells.

Nozato K, Fujita J, Kawaguchi M, Ohara G, Morishima Y, Ishii Y, Huang SK, Kokubu F, Satoh H, Hizawa N.

J Allergy (Cairo). 2011;2011:587204. doi: 10.1155/2011/587204. Epub 2011 Oct 13.

17.

The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases.

Pappu R, Ramirez-Carrozzi V, Sambandam A.

Immunology. 2011 Sep;134(1):8-16. doi: 10.1111/j.1365-2567.2011.03465.x. Epub 2011 Jul 4. Review.

18.

Structure and function of interleukin-17 family cytokines.

Zhang X, Angkasekwinai P, Dong C, Tang H.

Protein Cell. 2011 Jan;2(1):26-40. doi: 10.1007/s13238-011-1006-5. Epub 2011 Feb 20. Review.

19.

Signaling of interleukin-17 family cytokines in immunity and inflammation.

Chang SH, Dong C.

Cell Signal. 2011 Jul;23(7):1069-75. doi: 10.1016/j.cellsig.2010.11.022. Epub 2010 Dec 2. Review.

20.

Evolutionary divergence and functions of the human interleukin (IL) gene family.

Brocker C, Thompson D, Matsumoto A, Nebert DW, Vasiliou V.

Hum Genomics. 2010 Oct;5(1):30-55.

Items per page

Supplemental Content

Write to the Help Desk